MedPath

Trial of an app to support breast cancer survivors prescribed hormone therapy

Not Applicable
Conditions
Breast cancer
Cancer
Malignant neoplasm of breast
Registration Number
ISRCTN51581601
Lead Sponsor
King’s College London and Guy’s and St Thomas’ NHS Trust
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Ongoing
Sex
Female
Target Recruitment
2000
Inclusion Criteria

Phase one:
1. Diagnosed with primary breast cancer
2. Prescribed hormonal therapy within the last three years

Phase two:
1. =23 on the MARS
2. Has weekly access to smartphone or tablet
3. Has email address

Exclusion Criteria

1. Diagnosed with secondary or metastatic cancer
2. Prescribed duration of hormonal therapy is due to come to an end during trial
3. Current treatment for depression or psychiatric disorders
4. Not fluent in verbal and written English

Phase two:
1. Diagnosed with secondary or metastatic cancer
2. Prescribed duration of hormonal therapy is due to come to an end during trial
3. Current treatment for depression or psychiatric disorders
4. Not fluent in verbal and written English
5. Patient does not provide consent or refuses to be randomised
6. Patient is currently taking part in another trial

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath